INDCX
Price
$14.70
Change
-$0.07 (-0.47%)
Updated
Jul 2 closing price
Net Assets
2.3B
RGEBX
Price
$82.51
Change
-$0.81 (-0.97%)
Updated
Jul 2 closing price
Net Assets
360.63B
Interact to see
Advertisement

INDCX vs RGEBX

INDCX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
INDCX vs. RGEBX commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDCX is a Buy and RGEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 361B vs. INDCX (2.3B). INDCX (0.00) and RGEBX (0.00) have matching dividends . INDCX was incepted earlier than RGEBX: INDCX (18 years) vs RGEBX (12 years). INDCX (1.79) is less costly to investors than RGEBX (1.08). INDCX is a more actively managed with annual turnover of: 65.00 vs. RGEBX (32.00). RGEBX has a lower initial minimum investment than INDCX: RGEBX (250) vs INDCX (2500). INDCX annual gain was more profitable for investors over the last year : 11.87 vs. RGEBX (5.16). RGEBX return over 5 years is better than : 12.23 vs. INDCX (-11.71).
INDCXRGEBXINDCX / RGEBX
Total Expense Ratio1.791.08166%
Annual Report Gross Expense Ratio1.791.08166%
Fund Existence18 years12 years-
Gain YTD8.4077.631110%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.3B361B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year11.875.16230%
Returns for 3 years42.4440.43105%
Returns for 5 years-11.7112.23-96%
Returns for 10 years-5.71101.11-6%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IYH69.211.77
+2.62%
iShares US Healthcare ETF
SRTY22.050.43
+1.99%
ProShares UltraPro Short Russell2000
VGHY74.620.09
+0.12%
Vanguard High-Yield Active ETF
SYFI35.610.04
+0.11%
AB Short Duration High Yield ETF
BBH201.08N/A
N/A
VanEck Biotech ETF